written on 28.03.2014
pt:
Tags:
,

Takeda/Otsuka bolster GI presence via Japan P-CAB alliance

TAGS: ,

The tie-up will play to the strengths of both partners in the gastrointestinal area in Japan, where Otsuka markets the protective anti-ulcer agent Mucosta (rebamipide) and Takeda's Takepron (lansoprazole) is a leading PPI; however, both drugs are facing…

Latest Report